Ceribell’s LVO Stroke is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...
Ceribell, Inc. announced that the FDA has granted Breakthrough Device designation for its large vessel occlusion (LVO) stroke de ...
The Sunnyvale, CA-based firm's EEG-based solution uses artificial intelligence algorithms to identify large vessel occlusion ...
Zacks Investment Research on MSN
CBLL wins FDA breakthrough status for AI-based LVO stroke detection
CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...
MindRhythm’s Device, Harmony, is a Feasible Tool for Use in the Prehospital Setting CUPERTINO, CALIFORNIA, UNITED STATES, April 22, 2024 /EINPresswire.com ...
TipRanks on MSN
Ceribell wins FDA breakthrough status for LVO stroke tool
Ceribell, Inc. ( ($CBLL) ) has issued an announcement. On January 5, 2026, Ceribell announced that the U.S. Food and Drug Administration granted ...
SUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback